Effect of GTx-024, a selective androgen receptor modulator (SARM), on physical function in patients with non-small cell lung cancer (NSCLC) with cancer cachexia.
M. S. Steiner
Employment or Leadership Position - GTx
Stock Ownership - GTx
A. Dobs
Research Funding - GTx
M. L. Hancock
Employment or Leadership Position - GTx
Stock Ownership - GTx
M. A. Johnston
Employment or Leadership Position - GTx
Stock Ownership - GTx
G. Barnette
Employment or Leadership Position - GTx
Stock Ownership - GTx
S. Dodson
Employment or Leadership Position - GTx
Stock Ownership - GTx